FDA announces public workshop titled “Identification of Concepts and Terminology for Multi-Component Biomarkers

https://www.fda.gov/drugs/news-events-human-drugs/identification-concepts-and-terminology-multi-component-biomarkers-workshop-03232020-03232020?utm_campaign=SBIA%3A%20FDA%20announces%20public%20workshop%20titled%20%E2%80%9CIdentification%20of%20Concepts%20and%20Terminology%20for%20Multi-&utm_medium=email&utm_source=Eloqua

FDA announces public workshop titled “Identification of Concepts and Terminology for Multi-Component Biomarkers

Date: March 23, 2020 Time: 8:00 AM - 5:00 PM ET Location: FDA, White Oak Campus, The Great Room Building 31 10903 New Hampshire Avenue Silver Spring, MD 20903 United States The Food and Drug Administration (FDA) will hold a public workshop titled “Identification of Concepts and Terminology for Multi-Component Biomarkers" on March 23, 2020 at FDA’s White Oak Campus.  The purpose of the public workshop is to address the need to identify standardized high-level conceptual terminology, its potential hierarchy, and include specific language to describe the range of multi-component biomarkers and their application to decision-making. Learn more and Register